Protara Therapeutics Stock Price Prediction
| TARA Stock | USD 3.08 0.06 1.91% |
Momentum 43
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.51) | EPS Estimate Current Year (1.66) | EPS Estimate Next Year (1.91) | Wall Street Target Price 22.1667 | EPS Estimate Current Quarter (0.48) |
Using Protara Therapeutics hype-based prediction, you can estimate the value of Protara Therapeutics from the perspective of Protara Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Protara Therapeutics using Protara Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Protara using crowd psychology based on the activity and movement of Protara Therapeutics' stock price.
Protara Therapeutics Short Interest
A significant increase or decrease in Protara Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Protara. Short interest can provide insight into the potential direction of Protara Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 3.6489 | Short Percent 0.0586 | Short Ratio 7.94 | Shares Short Prior Month 2.2 M | 50 Day MA 3.1329 |
Protara Therapeutics Hype to Price Pattern
Investor biases related to Protara Therapeutics' public news can be used to forecast risks associated with an investment in Protara. The trend in average sentiment can be used to explain how an investor holding Protara can time the market purely based on public headlines and social activities around Protara Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Protara Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Protara Therapeutics.
Protara Therapeutics Implied Volatility | 1.48 |
Protara Therapeutics' implied volatility exposes the market's sentiment of Protara Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Protara Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Protara Therapeutics stock will not fluctuate a lot when Protara Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Protara Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Protara because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Protara Therapeutics after-hype prediction price | USD 3.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Protara Therapeutics Basic Forecasting Models to cross-verify your projections. Protara Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Protara Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Protara Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Protara Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Protara Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Protara Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Protara Therapeutics' historical news coverage. Protara Therapeutics' after-hype downside and upside margins for the prediction period are 0.15 and 7.53, respectively. We have considered Protara Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Protara Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Protara Therapeutics is based on 3 months time horizon.
Protara Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Protara Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Protara Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Protara Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 4.47 | 0.02 | 0.03 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.08 | 3.06 | 0.65 |
|
Protara Therapeutics Hype Timeline
Protara Therapeutics is at this time traded for 3.08. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.03. Protara is projected to decline in value after the next headline, with the price expected to drop to 3.06. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.65%, whereas the daily expected return is at this time at -0.26%. The volatility of related hype on Protara Therapeutics is about 3483.12%, with the expected price after the next announcement by competition of 3.11. About 76.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Protara Therapeutics recorded a loss per share of 1.49. The entity last dividend was issued on the 10th of January 2020. The firm had 1:40 split on the 10th of January 2020. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Protara Therapeutics Basic Forecasting Models to cross-verify your projections.Protara Therapeutics Related Hype Analysis
Having access to credible news sources related to Protara Therapeutics' direct competition is more important than ever and may enhance your ability to predict Protara Therapeutics' future price movements. Getting to know how Protara Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Protara Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TCON | TRACON Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RZLT | Rezolute | 0.06 | 41 per month | 2.39 | 0.22 | 6.44 | (4.55) | 36.39 | |
| XOMA | XOMA Corp | 0.19 | 8 per month | 2.52 | 0.08 | 5.23 | (3.84) | 19.22 | |
| VINC | Vincerx Pharma, Common | (0.06) | 7 per month | 0.00 | (0.33) | 8.57 | (19.38) | 64.36 | |
| LRMR | Larimar Therapeutics | 0.43 | 9 per month | 5.55 | 0.13 | 10.88 | (8.41) | 40.34 | |
| LYRA | Lyra Therapeutics | 0.15 | 8 per month | 7.90 | 0.09 | 18.00 | (15.85) | 342.66 |
Protara Therapeutics Additional Predictive Modules
Most predictive techniques to examine Protara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Protara using various technical indicators. When you analyze Protara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Protara Therapeutics Predictive Indicators
The successful prediction of Protara Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Protara Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Protara Therapeutics based on analysis of Protara Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Protara Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Protara Therapeutics's related companies. | 2022 | 2025 (projected) | Payables Turnover | 0.16 | 0.15 | Days Of Inventory On Hand | 1.7K | 839.45 |
Story Coverage note for Protara Therapeutics
The number of cover stories for Protara Therapeutics depends on current market conditions and Protara Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Protara Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Protara Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Protara Therapeutics Short Properties
Protara Therapeutics' future price predictability will typically decrease when Protara Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Protara Therapeutics often depends not only on the future outlook of the potential Protara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Protara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.6 M | |
| Cash And Short Term Investments | 170.3 M |
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |